Jan 13 (Reuters) - Gene sequencing company Illumina on Tuesday introduced a dataset that maps genetic changes to help accelerate drug discovery through artificial intelligence.
The company said it was partnering with drugmakers AstraZeneca, Merck and Eli Lilly for its Billion Cell Atlas, which will train advanced AI models at scale and advance research into fundamental disease mechanisms that have previously been out of reach.
Drug developers are increasingly adopting AI for discovery and safety testing to get faster and cheaper results, in line with the U.S. Food and Drug Administration's push to reduce animal testing in the near future.
Drug development software maker Certara and biotechs such as Schrodinger and Recursion Pharmaceuticals are using the booming technology to predict how experimental drugs might be absorbed, distributed or trigger toxic side-effects.
"We believe the Cell Atlas is a key development that will enable us to significantly scale AI for drug discovery," said Illumina CEO Jacob Thaysen.
The Atlas will capture how 1 billion individual cells respond to genetic changes via CRISPR across more than 200 disease-relevant cell lines.
These cell lines have been selected for their relevance to diseases, many of which have been historically difficult to decode, including immune disorders and cancer as well as cardiometabolic, neurological and rare genetic diseases.
The Atlas will enable users to characterize drug and disease mechanisms of action, explore potential new indications and validate candidate targets from human genetics.
(Reporting by Christy Santhosh in Bengaluru; Editing by Shilpi Majumdar)
LATEST POSTS
- 1
The most effective method to Safeguard Your Teeth from Acidic Food varieties and Beverages - 2Flourishing in Retirement: Individual Accounts of Post-Vocation Satisfaction
- 3Winter storms blanket the East, while the U.S. West is wondering: Where’s the snow?
- 4What's the Fate of 5G Innovation?
- 5Golan resident convicted of spying for Iran after passing tank movement, missile-impact data
- Vaccine committee votes to scrap universal hepatitis B shots for newborns despite outcry from children’s health experts
- Somaliland denies trading recognition with Israel for accepting Gazans
- Best Amusement Park in Europe: Where Do You Very much want to Visit?
- Argentina joins NASA’s moon return with microsatellite testing GPS beyond Earth
- Germany's first Omani LNG shipments arrive despite Middle East disruptions
- Baby takes 1st steps after receiving groundbreaking gene-edited therapy
- 10 Famous Frozen yogurt Flavors All over The Planet
- RFK Jr. succeeds in changing hepatitis B recommendation | The Excerpt
- The 15 Most Powerful Forerunners in Business
